The partnership involves the Government, Glasgow University, clinical trial provider IQVIA and pharma firm Novo Nordisk, who ...

For the first time in years, the obesity rate is falling in the US, with the rise of weight loss injections like Ozempic and ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Novo Nordisk raises its bid for obesity drugmaker Metsera to outmanoeuvre Pfizer, reshaping the fast-growing weight-loss ...

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...

Shares of Indian generic drugmaker Dr Reddy's Laboratories declined more than 5% on Thursday, after the firm received a non-compliance notice for its semaglutide injection in Canada, which analysts ...

Fridays Health is redefining modern weight care with a holistic telehealth platform that makes access to GLP-1 medications ...

A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...

Somehow, it’s becoming even harder to get a GLP-1.

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...